The largest database of trusted experimental protocols

Tryple express cell dissociation reagent

Manufactured by Thermo Fisher Scientific

TrypLE Express cell dissociation reagent is a ready-to-use, animal-component-free solution designed for the dissociation and detachment of adherent cells in cell culture applications. It is a proteolytic enzyme that effectively breaks down the extracellular matrix and cell-cell adhesions, allowing for the gentle harvesting of cells.

Automatically generated - may contain errors

2 protocols using tryple express cell dissociation reagent

1

Characterization of MDA-MB-231 Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines used for characterization were grown aseptically to 30–60% confluence at 37 °C in a humidified atmosphere of 5% CO2. MDA-MB-231 (triple-negative breast carcinoma, ATCC® HTB-26™) cells were grown in DMEM medium supplemented with 10% inactivated FBS and 1% penicillin/streptomycin. Adherent cells were dissociated with TrypLE express cell dissociation reagent (Gibco) and resuspended in complete media. For experiments related to Fig. 2, the cell line used was MDA-MB-231 cells that stably expressed firefly luciferase-enhanced green fluorescent protein (FLuc-eGFP), a generous gift from the Paulmurugan lab at Stanford University [69 (link)].
+ Open protocol
+ Expand
2

Cell Line Characterization and Spiking

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines used for characterization were grown to 30% to 60% confluence at 37 °C in a humid atmosphere of 5% CO 2 . Cell lines were evaluated for mycoplasma contamination by PCR (Venor GeM Mycoplasma Detection Kit) and authenticated by IDEXX BioResearch. MCF7 (breast carcinoma, ATCC) cells were cultured in RPMI medium supplemented with 10% fetal bovine serum (FBS) previously inactivated at 56 °C for 30 min, 1% penicillin/streptomycin (Invitrogen), and 0.01 mg/mL human recombinant insulin (Life Technologies). MDA-MB-231 (breast carcinoma, ATCC) cells were grown in DMEM medium supplemented with 10% inactivated FBS and 1% penicillin/streptomycin. HCC827 (lung carcinoma, ATCC) cells and H1975 (lung carcinoma, ATCC) cells were grown in RPMI medium supplemented with 10% inactivated FBS and 1% penicillin/ streptomycin. Adherent cells were dissociated with TrypLE express cell dissociation reagent (Gibco) and resuspended in complete media. Their viability and average diameter were measured using acridine orange, propidium iodide solution on a Cellometer K2 (Nexcelom). Cells (from 50 to 500 cells depending on the experiment) were then spiked into 0.5 to 4.0 mL healthy human blood diluted 10× in PBS pH 7.2, prior to injection through the chip.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!